Why is Suzhou Novoprotein Scientific Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 3.40%
- The company has been able to generate a Return on Capital Employed (avg) of 3.40% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -28.25% and Operating profit at -209.74% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 0.91% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -28.25% and Operating profit at -209.74% over the last 5 years
4
The company has declared Negative results for the last 10 consecutive quarters
- PRE-TAX PROFIT(Q) At CNY -15.82 MM has Fallen at -327.91%
- NET PROFIT(Q) At CNY -11.81 MM has Fallen at -1,330.37%
- OPERATING CASH FLOW(Y) Lowest at CNY 11.88 MM
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 7.84%, its profits have fallen by -771.6%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Suzhou Novoprotein Scientific Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Suzhou Novoprotein Scientific Co., Ltd.
-100.0%
0.47
38.12%
China Shanghai Composite
15.19%
1.01
14.58%
Quality key factors
Factor
Value
Sales Growth (5y)
-28.25%
EBIT Growth (5y)
-209.74%
EBIT to Interest (avg)
-11.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.07
Tax Ratio
1.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.40%
ROE (avg)
0.91%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.33
EV to EBIT
10.42
EV to EBITDA
15.87
EV to Capital Employed
-3.22
EV to Sales
-7.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-3.35%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
4What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 0.84%
RAW MATERIAL COST(Y)
Fallen by -21.74% (YoY
NET SALES(Q)
At CNY 33.15 MM has Grown at 28.96%
-18What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY -15.82 MM has Fallen at -327.91%
NET PROFIT(Q)
At CNY -11.81 MM has Fallen at -1,330.37%
OPERATING CASH FLOW(Y)
Lowest at CNY 11.88 MM
ROCE(HY)
Lowest at -2.97%
Here's what is working for Suzhou Novoprotein Scientific Co., Ltd.
Inventory Turnover Ratio
Highest at 0.84% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
At CNY 33.15 MM has Grown at 28.96%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by -21.74% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Suzhou Novoprotein Scientific Co., Ltd.
Pre-Tax Profit
At CNY -15.82 MM has Fallen at -327.91%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -11.81 MM has Fallen at -1,330.37%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 11.88 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)






